Keyphrases
Chikungunya Virus (CHIKV)
100%
Value Profile
100%
Vaccine Value
100%
Disease Burden
25%
Chronic Morbidity
25%
Virus
12%
Economic Loss
12%
Alphavirus
12%
Chronic Disease
12%
Acute Disease
12%
Mosquito-borne
12%
Disease Stage
12%
Antiviral Vaccines
12%
Antiviral Drugs
12%
Public Health Impact
12%
Causative Agents
12%
Nonprofit Organizations
12%
Infection Control
12%
Knowledge Gaps
12%
Low Mortality
12%
Normal Activity
12%
Chronic Arthritis
12%
Chikungunya Vaccine
12%
Severe Outcomes
12%
Societal Values
12%
Like Products
12%
Public Health Economics
12%
Health Value
12%
Low-middle Income Countries
12%
Development pipeline
12%
Persistent Arthralgia
12%
Disease Losses
12%
Economic Value
12%
Subject Matter Experts
12%
Acute Morbidity
12%
Public-private Partnership
12%
Vaccine Impact
12%
Deprived Areas
12%
Publicly Available Information
12%
Economically Deprived
12%
Multilateral Organizations
12%
Medicine and Dentistry
Chikungunya
100%
Chikungunya Virus
80%
Disease
60%
Public Health
40%
Infection
20%
Antivirus Agent
20%
Alphavirus
20%
Virus Vaccine
20%
Chronic Disease
20%
Arthralgia
20%
Acute Disease
20%
Chronic Arthritis
20%
Low and Middle Income Countries
20%
Public-Private Partnership
20%
Infection Control
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chikungunya
100%
Chikungunya Virus
80%
Disease
60%
Infection
40%
Chronic Disease
20%
Antivirus Agent
20%
Acute Disease
20%
Virus Vaccine
20%
Alphavirus
20%
Arthralgia
20%
Chronic Arthritis
20%